Cancer Genetics to Present at the Annual 33rd ROTH Conference
Registration: Mr. Roberts will highlight the Company's recent transformational business strategy, including the Company’s proposed merger with StemoniX, Inc., and elaborate on the broader going- forward corporate vision. If you are an investor and would like to attend the Company’s presentation, please click on the following link (https://www.meetmax.com/sched/event_70981/conference_register.html) to register for the Annual 33 rd ROTH Conference. Once your registration is confirmed, you will be prompted to log into the conference website and will be able to request a one-on-one meeting ...
Source: globenewswire.com